SPOTLIGHT: Gates backs new vaccine technology

PATH is using a $39 million grant from the Gates Foundation to help developing countries identify ways to manufacture and stockpile vaccines that could be used to defend their populations against an influenza pandemic. Developed countries have already spent millions of dollars stockpiling hundreds of millions of doses of flu vaccine. But PATH notes that developing countries are likely to be left to their own devices in the event of a pandemic. The Gates moneys will go to public and private vaccine development partnerships. Report

Suggested Articles

At ASH, Dana-Farber researchers presented promising preclinical data on AMG 701, Amgen's long-lasting BiTE for multiple myeloma, but rivals loom.

The takeover, the first of Paul Hudson’s time as CEO, will give Sanofi an IL-2 drug it thinks can become a foundation of future cancer combinations.

A phase 1/2b test showed Roche's antibody mosunetuzumab can trigger durable responses in a significant minority of hard-to-treat NHL patients.